Lista de obras - Nina Friis-Møller - Dominio Público Uruguay

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study

artículo científico publicado en 2015

Antiretroviral therapy as a cardiovascular disease risk factor: fact or fiction? A review of clinical and surrogate outcome studies

artículo científico publicado en 2008

Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

artículo científico publicado en 2015

Body Mass Index and Risk of Infections Among Women in the Danish National Birth Cohort

artículo científico publicado en 2016

Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?

scientific article published on 12 September 2007

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

artículo científico publicado en 2003

Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study

artículo científico publicado en 2004

Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.

artículo científico publicado en 2010

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

artículo científico publicado en 2008

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

scientific article published on 01 April 2007

Combination antiretroviral therapy and the risk of myocardial infarction

artículo científico publicado en 2003

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

artículo científico publicado en 2009

Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study

artículo científico publicado en 2010

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

artículo científico publicado en 2008

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

artículo científico

Highly active antiretroviral therapy and coronary heart disease: the need for perspective.

artículo científico publicado en 2001

Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV

artículo científico publicado en 2016

Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis

artículo científico publicado en 2006

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

artículo científico publicado en 2009

Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate

artículo científico

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

artículo científico publicado en 2008

Incidence of abacavir hypersensitivity reactions in euroSIDA.

artículo científico

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.

artículo científico publicado en 2011

Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial

artículo científico publicado en 2017

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

artículo científico publicado en 2004

Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function

artículo científico publicado en 2003

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

artículo científico publicado en 2009

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

artículo científico publicado en 2006

Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

artículo científico publicado en 2003

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

artículo científico publicado en 2010

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

artículo científico publicado en 2012

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

artículo científico publicado en 2005

Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study

artículo científico publicado en 2008

Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients

article

Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study

artículo científico publicado en 2002

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

artículo científico publicado en 2005

Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?

artículo científico

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

artículo científico publicado en 2010

The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology

artículo científico publicado en 2011

The prevalence and clinical significance of intestinal parasites in HIV-infected patients in Denmark

artículo científico publicado en 2010

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

artículo científico publicado en 2008

[Carbon monoxide poisoning]

artículo científico publicado en 2009

Lista de obras de Nina Friis-Møller

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study

Antiretroviral therapy as a cardiovascular disease risk factor: fact or fiction? A review of clinical and surrogate outcome studies

Association between tumour necrosis factor-α inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study

Body Mass Index and Risk of Infections Among Women in the Danish National Birth Cohort

Can the risk of cardiovascular disease in HIV-infected patients be estimated from conventional risk prediction tools?

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study

Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study

Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.

Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

Class of Antiretroviral Drugs and the Risk of Myocardial Infarction

Combination antiretroviral therapy and the risk of myocardial infarction

Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study).

Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

Highly active antiretroviral therapy and coronary heart disease: the need for perspective.

Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV

Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate

Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

Incidence of abacavir hypersensitivity reactions in euroSIDA.

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.

Initial Serological Response after Prime-boost Pneumococcal Vaccination in Rheumatoid Arthritis Patients: Results of a Randomized Controlled Trial

Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?

Lipodystrophy in human immunodeficiency virus patients impairs insulin action and induces defects in beta-cell function

Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study

Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) study.

Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study

Predictors of hypertension and changes of blood pressure in HIV-infected patients.

Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study

Prevention Strategies for Cardiovascular Disease in HIV-Infected Patients

Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study

Risk of AIDS and death at given HIV-RNA and CD4 cell count, in relation to specific antiretroviral drugs in the regimen

Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now?

Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study

The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology

The prevalence and clinical significance of intestinal parasites in HIV-infected patients in Denmark

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

[Carbon monoxide poisoning]